Marico Kaya Enterprises Limited

NSE: MAKE | ISIN: INE432P01015
|

HDFC Securities
A pioneer in cosmetic dermatology, Kaya remains unchallenged in the organised skin clinic space in India. Management is confident of 20% revenue CAGR over the next 3-5 years, a claim that looks surpassable. A new found focus on product sales adds synergies to its story. Kaya turned profitable in FY14 (after 11 years of losses) and has significant untapped operating leverage in its operations.
More from Marico Kaya Enterprises Limited
Recommended